Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apoptosis in hematological disorders.

Klaus Michael Debatin1, Karsten Stahnke, Simone Fulda

  • 1University Children's Hospital, Prittwitzstr. 43, 89075 Ulm, Germany. klaus-michael.debatin@medizin.uni-ulm.de

Seminars in Cancer Biology
|March 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Notice to "Genes Involved in Apoptosis Regulation: Implications for Cancer Therapy".

Current genomics·2025
Same author

Correction to: NF-κB contributes to Smac mimetic-conferred protection from tunicamycin-induced apoptosis.

Apoptosis : an international journal on programmed cell death·2025
Same author

Correction: Editorial Expression of Concern: Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer.

Oncogene·2024
Same author

Editorial Expression of Concern: Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer.

Oncogene·2024
Same author

Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial.

The Lancet. Oncology·2024
Same author

Mathematical modeling of the molecular switch of TNFR1-mediated signaling pathways applying Petri net formalism and in silico knockout analysis.

PLoS computational biology·2022
Same journal

Unveiling tumor heterogeneity by single cell RNA-sequencing: From basic considerations to clinical applications.

Seminars in cancer biology·2026
Same journal

Hidden architecture of resistance: The extracellular matrix in melanoma's immune landscape.

Seminars in cancer biology·2026
Same journal

Microfluidic technologies for extracellular vesicle isolation and analysis: Implications for translational applications in cancer therapy.

Seminars in cancer biology·2026
Same journal

Exploring glioblastoma microenvironment using organoids: opportunities, limitations, and emerging concepts.

Seminars in cancer biology·2026
Same journal

Special issue: Lipid metabolic alterations in cancer: Pathogenic mechanisms, therapies and common pathophysiology with cardiovascular disease.

Seminars in cancer biology·2026
Same journal

Systemic lipid metabolic alterations and the tumor microenvironment: A hidden driver of immune dysfunction.

Seminars in cancer biology·2026
See all related articles

Apoptosis, or programmed cell death, is crucial for tissue balance, especially in blood cells. Understanding how cancer cells evade apoptosis and how therapies induce it is key to treating leukemia and lymphoma.

Area of Science:

  • Cell Biology
  • Oncology
  • Immunology

Background:

  • Apoptosis (programmed cell death) regulates tissue homeostasis, particularly in high-turnover systems like hematopoietic cells.
  • Dysregulation of cell proliferation and apoptosis contributes to diseases such as cancer.
  • Current leukemia and lymphoma therapies often rely on inducing apoptosis in malignant cells.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying tumor cell evasion of apoptosis.
  • To understand how cytotoxic therapies induce apoptosis in cancer cells.
  • To link normal growth control, malignant transformation, and therapeutic response through the lens of apoptosis.

Main Methods:

  • Molecular pathway analysis of apoptosis.
  • Investigation of tumor cell resistance mechanisms.

Related Experiment Videos

  • Assessment of apoptosis induction by cytotoxic and immunotherapies.

    • Main Results:

    • Identified key molecular events enabling tumor cells to escape programmed cell death.
    • Characterized pathways through which cancer therapies trigger apoptosis.
    • Established a framework connecting normal cell regulation, cancer development, and treatment efficacy.

    Conclusions:

    • Understanding apoptosis evasion and induction is critical for developing effective cancer treatments.
    • Apoptosis pathways serve as a paradigm for linking normal growth, malignancy, and therapy response.
    • Targeting apoptosis offers a promising strategy for treating hematological malignancies.